首页> 外文期刊>Journal of pharmaceutical sciences. >On Prilling of Hydrophilic Microgels in Lipid Dispersions Using Mono-N-Carboxymethyl Chitosan for Oral Biologicals Delivery
【24h】

On Prilling of Hydrophilic Microgels in Lipid Dispersions Using Mono-N-Carboxymethyl Chitosan for Oral Biologicals Delivery

机译:单-N-羧甲基壳聚糖在脂质分散体中亲水微凝胶的造粒研究

获取原文
获取原文并翻译 | 示例
       

摘要

Oral delivery of biologicals is a thriving field in pharmaceutics and the first challenge is to achieve a stable drug product. Interesting is prilling of a drug-containing polymeric solution as microgel into an aqueous hardening bath where crosslinking occurs. However, to deliver a final dosage form, for example, soft gelatin capsules, the aqueous hardening bath must be removed, thus leading to manufacturing processes that are potentially harmful for the active. The current work introduces a prilling method with a lipid-based hardening bath, which could theoretically be filled directly into capsules. Bovine serum albumin (BSA) and mono-N-carboxymethyl chitosan (MCC) were selected as model biological and encapsulating polymer, respectively. Several nonaqueous formulations of the receiving bath were investigated; calcium chloride was added to these formulations to allow the MCC gelling. The obtained microgels had average diameters of approximate to 300 m and spherical to toroidal shapes, according to the hardening bath composition. Along with a high encapsulation efficiency (>85%), the microgels protected the BSA from any denaturing effect of the hardening bath. The release study showed a rather fast BSA release within the first 10 min from most microgels. This novel approach demonstrated technical viability for encapsulation of biologicals using lipid formulations regarding oral delivery. (c) 2014 Wiley Periodicals, Inc. and the American Pharmacists Association J Pharm Sci 103:3675-3687, 2014
机译:口服生物制剂在药物学领域是一个蓬勃发展的领域,第一个挑战是获得稳定的药物产品。有趣的是将含药物的聚合物溶液(如微凝胶)造粒到发生交联的水性硬化浴中。然而,为了递送最终剂型,例如软明胶胶囊,必须去除水性硬化浴,从而导致可能对活性物质有害的制造过程。当前的工作介绍了一种基于脂质的硬化浴的造粒方法,理论上可以直接填充到胶囊中。分别选择牛血清白蛋白(BSA)和单-N-羧甲基壳聚糖(MCC)作为模型生物和包囊聚合物。研究了接收浴的几种非水性配方;将氯化钙添加到这些制剂中以使MCC胶凝。根据硬化浴组成,所获得的微凝胶的平均直径约为300m,并且具有球形至环形形状。微胶囊具有高封装效率(> 85%),可保护BSA免受硬化浴的任何变性作用。释放研究表明,大多数微凝胶在最初的10分钟内BSA释放速度都相当快。这种新颖的方法证明了使用脂质制剂进行口服给药封装生物制剂的技术可行性。 (c)2014年Wiley Periodicals,Inc.和美国药剂师协会J Pharm Sci 103:3675-3687,2014

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号